SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Ajootian who wrote (987)7/9/1998 1:57:00 PM
From: cav  Read Replies (2) of 10280
 
The convertible debt is no longer a factor as the dilutive effects of this have already been factored into the earnings models. anyone who does not feel this debt will be converted eventually should short the stock now. The talk on options also appears dubious, what is the open interest on these instruments? In my view you can also throw the charts out the window, the story is the drugs and as long as progress continues on that front shareholders will be richly rewarded. I want the stock to rise everyday also, but i am not concerned with short-term market noise but rather the underlying story behind the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News